Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
Study Number: 

NCG 273015

Phase: 
3
Trial categories: 
Leukemia
Pediatric Cancers
Immunotherapy
Principal Investigator: